Brought to you by 
Colibri Heart Valve, Venus MedTech create Asian joint venture
08 Jun 2022
Executive Summary
Colibri Heart Valve LLC and fellow private cardiovascular device firm Venus MedTech (Hangzhou) Inc. are establishing a joint venture to develop and commercialize structural heart valve products for the Chinese and emerging Asian markets.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
- Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Alliance
- Joint Venture
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Colibri Heart Valve, Venus MedTech create Asian joint venture
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice